Clinical Trial Update: Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)

View source ↗

Summary

NHGRI-sponsored clinical trial update on individuals with Generalized Arterial Calcification of Infancy and Autosomal Recessive Hypophosphatemic Rickets Type 2;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Recessive Hypophosphatemic Rickets Type
• Generalized Arterial Calcification of Infancy

Snippet

Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Generalized Arterial Calcification of Infancy, Autosomal Recessive Hypophosphatemic Rickets Type2 | Status: COMPLETED